Mbx Biosciences, Inc. · NASDAQ:MBX
Orbimed Advisors LLC reported a 6.40% stake in Mbx Biosciences, Inc. (Schedule 13D/A)
Event Aug 6, 2026 · Filed Aug 10, 2026
Orbimed Advisors LLC reported a 6.40% stake in Mbx Biosciences, Inc., 3,074,853 shares, with active intent on Aug 6, 2026. Filed Aug 10, 2026 (Schedule 13D/A).
- Stake
- 6.40%
- Shares
- 3,074,853
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ORBIMED ADVISORS LLC | 6.40% | 3,074,853 |
| ORBIMED CAPITAL GP VII LLC | 5.20% | 2,505,150 |
| ORBIMED GENESIS GP LLC | 1.20% | 569,703 |
Source
Related
- Mbx Biosciences, Inc.
- Orbimed Advisors LLC
- Mbx Biosciences, Inc. shareholders
- Schedule 13D/A · Orbimed Advisors LLC · Feb 11, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Sep 30, 2025
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13D/A · James N. Topper · Aug 10, 2026
- Form 4 · Azoulay Salomon · Aug 5, 2026
- Form 4 · Smither John W · Aug 4, 2026
- Form 4 · Hoerter Steven L. · Aug 4, 2026